Dr. Sarah Mohiuddin of C.S. Mott Children’s Hospital is addressing misconceptions about autism after a recent debate linked Tylenol use during pregnancy to the condition. She emphasizes that genetics, not parental choices or medications, is the primary factor. Her team is launching a national curriculum, TEAM, to train health providers in autism care and highlight emerging research, including experimental treatments, while U-M researchers continue advancing genetic and clinical studies to better understand autism. Continue reading here.
